← Back to Clinical Trials
Recruiting NCT06018831

NCT06018831 Urine and Ultrasound Screening for Kidney Disease in Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06018831
Status Recruiting
Phase
Sponsor Children's Hospital of Fudan University
Condition Kidney Diseases
Study Type INTERVENTIONAL
Enrollment 13,000 participants
Start Date 2022-04-12
Primary Completion 2028-02

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 6 Years
Study Type INTERVENTIONAL
Interventions
Urine and Ultrasound Screening

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 13,000 participants in total. It began in 2022-04-12 with a primary completion date of 2028-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to early detect kidney disease in the natural population cohort of children by urine and ultrasound screening, to assist in the precise prevention and treatment of children's kidney disease, and to establish a risk prediction system for children's kidney disease. About 10,000 children called KunQi Cohort are born in Jiangsu Province(8,000 in Kunshan and 2,000 in Qidong) and about 3,000 born in Shanghai. Through the project, child who is found with abnormal urine or ultrasound result will be referred to Children's Hospital of Fudan University to get further examination and treatment.

Eligibility Criteria

Inclusion Criteria: * All consecutive live newborn infants(regardless of physical condition) * Complete at least 3 years of follow-up Exclusion Criteria: * Declining the screening * Missing

Contact & Investigator

Central Contact

Yihui Zhai

✉ marinezyh@163.com

📞 +8613916488230

Frequently Asked Questions

Who can join the NCT06018831 clinical trial?

This trial is open to participants of all sexes, up to 6 Years, studying Kidney Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06018831 currently recruiting?

Yes, NCT06018831 is actively recruiting participants. Contact the research team at marinezyh@163.com for enrollment information.

Where is the NCT06018831 trial being conducted?

This trial is being conducted at Nantong, China, Suzhou, China.

Who is sponsoring the NCT06018831 clinical trial?

NCT06018831 is sponsored by Children's Hospital of Fudan University. The trial plans to enroll 13,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology